Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Karyopharm Therapeutics

Karyopharm Therapeutics reported $69.6M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
AbbVie ABBV:US USD 9.46B 162M
Abbott ABT:US USD 8.24B 549M
Amgen AMGN:US USD 4.07B 538M
AstraZeneca AZN:LN USD 8.33B 1.78B
Avrobio Inc AVRO:US USD 25.22M 37K
BioCryst Pharmaceuticals BCRX:US USD 97.19M 28.66M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Eli Lilly LLY:US USD 5.47B 600K
Enanta Pharmaceuticals ENTA:US USD 57.25M 3.65M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Incyte Corp INCY:US USD 783.9M 72.7M
J&J JNJ:US USD 25.48B 5.98B
Karyopharm Therapeutics KPTI:US USD 69.6M 2.15M
MacroGenics MGNX:US USD 62.92M 1.81M
Merck & Co MRK:US USD 10.76B 371M
Mirati Therapeutics MRTX:US USD 200.99M 11.67M
Nektar Therapeutics NKTR:US USD 156.3M 81.81M
Novartis NOVN:VX USD 10.35B 700M
Novartis NVS:US USD 10.35B 700M
Pfizer PFE:US USD 11.5B 7.63B
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B
Sangamo BioSciences SGMO:US USD 139.92M 57.3M
Takeda 4502:JP JPY 867.59B 81.97B
TG Therapeutics TGTX:US USD 44.79M 7.35M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
Xencor XNCR:US USD 78.33M 14.02M